Addyi was initial authorised with the FDA in August 2015 to treat hypoactive sexual desire dysfunction (HSDD) in premenopausal Females. Which is just another way of saying it boosts intercourse drive (also known as libido) in Females who have not achieved menopause. It was the 1st this sort of drug https://stephenb063jkj0.theblogfairy.com/profile